Intrathecal clonidine in the treatment of intractable pain: A phase I/II study

Pain Medicine

Volumn 3, Issue 2, 2002, Pages 85-91

  Hassenbusch, Samuel J ^a   Gunes, Seval ^a   Wachsman, Seth ^a   Willis, K Dean ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b Alabama Pain Center Huntsville   (United States)

Author keywords

Chronic pain; Clonidine; Intrathecal; Neuropathic pain; Programmable infusion system

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; CLONIDINE; CORTICOSTEROID; GABAPENTIN; MEXILETINE; MORPHINE; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PSYCHOTROPIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; IMPOTENCE; INFUSION PUMP; INFUSION SYSTEM; INTRACTABLE PAIN; LETHARGY; LONG TERM CARE; MALAISE; MALE; MONOTHERAPY; PAIN ASSESSMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHYSICAL EXAMINATION; REBOUND; SCORING SYSTEM; SELF REPORT; SIDE EFFECT; TITRIMETRY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0036342075     PISSN: 15262375     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4637.2002.02014.x     Document Type: Article

References (42)

1. Intrathecal drug therapy for chronic pain: From basic science to clinical practice
2. Epidural and spinal agents for postoperative analgesia
3. Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain: A review of the literature
4. Neuraxial infusion for pain control: When, why, and what to do after the implant
5. Oral clonidine premedication enhances postoperative analgesia by epidural morphine
6. Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage 'enriched enrollment' design
7. Adding clonidine to lidocaine for intravenous regional anesthesia prevents tourniquet pain
8. Epidural clonidine or bupivacaine as the sole analgesic agent during and after abdominal surgery: A comparative study
9. Enhancement of intrathecal lidocaine by addition of local and systemic clonidine
10. Extradural clonidine combined with sufentanil and 0.0625% bupivacaine for analgesia in labour
11. Comparison of 0.125% bupivacaine with 0.125% bupivacaine and clonidine as extradural analgesia in the first stage of labour
12. Epidural fentanyl, adrenaline and clonidine as adjuvants to local anaesthetics for surgical analgesia: Meta-analyses of analgesia and side-effects
13. Enhancement of analgesic effect of intrathecal neostigmine and clonidine on bupivacaine spinal anesthesia
14. Epidural clonidine treatment for refractory reflex sympathetic dystrophy
15. Epidural clonidine analgesia for intractable cancer pain
16. Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen
17. Distribution of alpha 2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents
18. Reassessment of verbal and visual analog ratings in analgesic studies
19. Comparisons between patient's and nurse's assessment of pain and medication efficacy in severe burn injuries
20. Reflex sympathetic dystrophy: Changing concepts and taxonomy
21. Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing
22. Presynaptic alpha 2 adrenoceptors inhibit glutamate release from rat spinal cord synaptosomes
23. Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by alpha-adrenergic receptor antagonists
24. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists
25. Differential effects of epidural morphine in the treatment of cancer-related pain
26. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
27. The Edmonton Staging System (Ess) for cancer pain: A prospective multicenter study
28. Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids
29. The nature of opioid responsiveness and its implications for neuropathic pain: New hypotheses derived from studies of opioid infusions
30. Pain characterization in cancer patients and the analgetic response to epidural morphine
31. Epidural opiates and local anesthetics for the management of cancer pain
32. The role of epidural clonidine in the treatment of patients with intractable pain
33. Role of spinal noradrenergic system in transmission of pain in patients with spinal cord injury
34. Spinal infusion of opiate and alpha-2 agonists in rats: Tolerance and cross-tolerance studies
35. A cholinergic interaction in alpha 2 adrenoceptor-mediated antinociception in sheep
36. Intravenous morphine increases release of nitric oxide from spinal cord by an alpha-adrenergic and cholinergic mechanism
37. Intrathecal clonidine alleviates allodynia in neuropathic rats: Interaction with spinal muscarinic and nicotinic receptors
38. The neurotoxicity of drugs given intrathecally (spinal)
39. Evidence-based review of the literature on intrathecal delivery of pain medication
40. Complex regional pain syndromes: Guidelines for therapy
41. Current practices in intraspinal therapy-A survey of clinical trends and decision making
42. Clinical guidelines for intraspinal infusion: Report of an expert panel